Viamet Pharmaceuticals Receives $3,000,100 New Funding Round

  • Feed Type
  • Date
    12/31/2012
  • Company Name
    Viamet Pharmaceuticals
  • Mailing Address
    4505 Emperor Blvd. Durham, NC 27703 USA
  • Company Description
    Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
  • Website
    http://www.viamet.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,000,100
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy